Inj. Halopid 5 mg/ml information and price in Bangladesh

Information: Inj. Halopid 5 mg/ml

Therapeutic action – Antipsychotic (neuroleptic) Indications – Acute or chronic psychosis – Severe anxiety not controlled by benzodiazepines Presentation – 5 mg tablet – 2 mg/ml oral solution (1 ml = 20 drops) Also comes in 0.5 and 2 mg tablets. Dosage – Acute or chronic psychosis Adult: 2 to 10 mg/day in 2 divided doses. If necessary, these doses may be gradually increased up to 20 mg/day according to clinical response. Once the patient is stable, the maintenance dose is administered once daily in the evening. – Severe anxiety not controlled by benzodiazepines Adult: 1 mg/day (10 drops/day) in 2 divided doses – Whatever the indication, reduce the dose by half in elderly patients. – Use the lowest effective dose, especially in the event of prolonged treatment. Duration – Acute psychosis: minimum 3 months; chronic psychosis: minimum one year. The treatment should be discontinued gradually (over 4 weeks). If signs of relapse occur, increase the dose. – Severe anxiety: maximum 4 weeks. Contra-indications, adverse effects, precautions – Do not administer to patients with cardiac disorders (cardiac failure, recent myocardial infarction, conduction disorders, bradycardia, etc.); to elderly patients with dementia (e.g. Alzheimer's disease). – Administer with caution and carefully monitor use in patients > 60 years and patients with hypokalaemia, hyperthyroidism, renal or hepatic impairment, Parkinson's disease. – May cause: drowsiness (caution when driving/operating machinery), extrapyramidal syndrome, early and tardive dyskinesia, sexual dysfunction, QT-prolongation, ventricular arrhythmia, orthostatic hypotension; neuroleptic malignant syndrome (unexplained hyperthermia with neuromuscular disorders), rare but requiring immediate treatment discontinuation. – In the event of extrapyramidal symptoms, combine with biperiden. – Avoid combination with: carbamazepine, rifampicin, fluoxetine, lithium, drugs that prolong the QT interval (amiodarone, chloroquine, erythromycin, fluconazole, mefloquine, pentamidine, quinine). – Avoid alcohol during treatment. – Pregnancy: re-evaluate whether the treatment is still necessary; if it is continued, monitor the newborn infant for reversible extrapyramidal effects (tremors) if the mother was under high dose treatment in the 3rd trimester. – Breast-feeding: avoid; if absolutely necessary, administer less than 5 mg/day. Remarks – Haloperidol produces less orthostatic hypotension than chlorpromazine and has little anticholinergic effects. It is less sedative than chlorpromazine but produces more extrapyramidal symptoms. – Storage: below 25°C

Caution: Inj. Halopid 5 mg/ml

Before taking Inj. Halopid 5 mg/ml, inform your doctor if you or your child have liver or kidney problems or any allergies. It should be used with caution in patients with liver problems due to alcohol to prevent the risk of liver damage.

Inj. Halopid 5 mg/ml should be used with caution in pregnant women only if clearly advised by the doctor and can be used in breastfeeding women.

Inj. Halopid 5 mg/ml is not recommended for use in children less than 10 years of age and should be used with caution in elderly patients.

Consult your doctor if you experience any side effects or unusual effects during treatment with Inj. Halopid 5 mg/ml.

Safety: Inj. Halopid 5 mg/ml

It is unsafe to consume alcohol with Inj. Halopid 5 mg/ml